Patents by Inventor Robert Brooke

Robert Brooke has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 12599651
    Abstract: A combination of medications and medication doses is disclosed whereby age-related changes in systemic inflammation, cancer risk, heart disease risk, CD38 expression, hair color, thymotrophic hormones, immune cell populations, the CD4/CD8 cell ratio, bone marrow density, thymus structure, kidney function, and epigenetic age can be reversed in humans. Surprisingly, agents that accelerate the growth of cells reduce cancer risk, agents that intensify immune responses attenuate age-related inflammation, agents with no prior connection to hair color reverse age-related hair whitening, and a combination of agents that induces IGF-1, a hormone previously thought to drive systemic aging, results in a reversal of systemic aging as documented by an epigenetic clock. Medication combinations useful in the present invention include human growth hormone (GH) or GH releasers, dehydroepiandrosterone (DHEA), and metformin.
    Type: Grant
    Filed: July 3, 2023
    Date of Patent: April 14, 2026
    Assignee: INTERVENE IMMUNE INC.
    Inventors: Gregory Fahy, Robert Brooke
  • Publication number: 20240299502
    Abstract: A combination of medications and medication doses is disclosed whereby age-related changes in systemic inflammation, cancer risk, heart disease risk, CD38 expression, hair color, thymotrophic hormones, immune cell populations, the CD4/CD8 cell ratio, bone marrow density, thymus structure, kidney function, and epigenetic age can be reversed in humans. Surprisingly, agents that accelerate the growth of cells reduce cancer risk, agents that intensify immune responses attenuate age-related inflammation, agents with no prior connection to hair color reverse age-related hair whitening, and a combination of agents that induces IGF-1, a hormone previously thought to drive systemic aging, results in a reversal of systemic aging as documented by an epigenetic clock. Medication combinations useful in the present invention include human growth hormone (GH) or GH releasers, dehydroepiandrosterone (DHEA), and metformin.
    Type: Application
    Filed: July 3, 2023
    Publication date: September 12, 2024
    Applicant: INTERVENE IMMUNE INC.
    Inventors: Gregory Fahy, Robert Brooke
  • Patent number: 5680789
    Abstract: There is disclosed a tool for bending wire, electrical cable, tube and rod. The tool comprises a base plate. On the first surface of the base plate there is a socket for receiving the drive stud from a ratchet wrench or there is a recess in the base plate for receiving the drive stud from a ratchet wrench. On the second surface there are two spaced-apart guides. The wire for electrical cable or tube or rod can be placed between the two spaced-apart guides. The tool can be moved and rotated so as to bend the wire, electrical cable, tube or rod to the desired configuration. A guide may have a roughened surface or knurled surface to assist in positioning the wire or rod being worked with the tool.
    Type: Grant
    Filed: August 20, 1996
    Date of Patent: October 28, 1997
    Inventor: Robert Brooke
  • Patent number: D388673
    Type: Grant
    Filed: November 13, 1995
    Date of Patent: January 6, 1998
    Inventor: Robert Brooke